Editorial
January 14, 2022
Alzheimer’s Disease and COVID-19 Share Genetic Risk Factor
Recent findings could open the door to new targets for drug development or to the tracking of disease progression in either disease, and they suggest that treatments could be used for both conditions.
December 17, 2021
Digesting COVID’s Impact on Gut Health
November 19, 2021
Weighing the Impact of Obesity on Diabetes
October 15, 2021
Scientists Isolate New, Potent Antibody Against SARS-CoV-2
September 17, 2021
Pregnant Women Fare Well With COVID Vaccine, Survey Finds
August 12, 2021
Pediatric Antibiotic Prescriptions Plummet During Pandemic
May 14, 2021
Pandemic Fomenting Familial Mental Health Challenges
April 16, 2021
Will COVID-19 Vaccines Require Regular Updates?
March 9, 2021
Opioid-Use Policies Causing Unintended Consequences
February 12, 2021
Metformin Reduces Death Risk in COVID-19 Patients With Diabetes
January 19, 2021
COVID-19 Conferring Worse Stroke Outcomes
Continuing Education
$6.97 Per CE Exam or $59 for 12 Lessons
-
Neurology • January 2024 • 2.00 Credits
The Pharmacologic Management of Migraine
-
Gastroenterology • December 2023 • 2.00 Credits
Pharmacist Review of Loperamide Abuse
-
• November 2023 • 2.00 Credits
Update on the Management of Diabetic Kidney Disease
Copyright © 2000 - 2022 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.